Open AccessAcute disseminated encephalomyelitis in a patient vaccinated against SARS‐CoV‐2
Author(s) -
Kania Karolina,
Ambrosius Wojciech,
Tokarz Kupczyk Elzbieta,
Kozubski Wojciech
Publication year - 2021
Publication title -
annals of clinical and translational neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.824
H-Index - 42
ISSN - 2328-9503
DOI - 10.1002/acn3.51447
Subject(s) - medicine , acute disseminated encephalomyelitis , vomiting , methylprednisolone , encephalomyelitis , nausea , demyelinating disease , urinary retention , magnetic resonance imaging , vaccination , multiple sclerosis , spinal cord , disease , pediatrics , anesthesia , surgery , immunology , radiology , psychiatry
Acute disseminated encephalomyelitis (ADEM) is a demyelinating disease, and there are some data that link this event with various vaccinations. We report a young female admitted to the hospital with headache, fever, back pain, nausea, vomiting, and urinary retention. Two weeks prior, she received the first dose of SARS‐CoV‐2 mRNA vaccine. Brain and spinal cord magnetic resonance imaging (MRI) showed distinctive for ADEM widespread demyelinating lesions. The patient was successfully treated with methylprednisolone.